HS
ZYME icon

HighVista Strategies’s Zymeworks ZYME Stock Holding History

HighVista Strategies’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$889K Sell
34,013
-72
-0.2% -$1.83K 0.2% 128
2026
Q1 		$853K Buy
+34,085
New +$806K 0.24% 126
2025
Q2 		– Sell
-41,607
Closed -$496K – 177
2025
Q1 		$496K Buy
+41,607
New +$567K 0.19% 127
2021
Q3 		– Sell
-25,452
Closed -$883K – 143
2021
Q2 		$883K Buy
25,452
+4,450
+21% +$141K 0.63% 28
2021
Q1 		$663K Buy
21,002
+6,394
+44% +$260K 0.49% 46
2020
Q4 		$690K Sell
14,608
-1,702
-10% -$79K 0.44% 54
2020
Q3 		$760K Buy
16,310
+4,717
+41% +$162K 0.55% 19
2020
Q2 		$418K Buy
+11,593
New +$427K 0.35% 52

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

HighVista Strategies's ZYME Position: Q2 2026 in Review

HighVista Strategies reduced its Zymeworks (ZYME) stake by 0.21% in Q2 2026, selling an estimated $1.83K and leaving 34,013 shares worth $889K. The position accounts for 0.2% of the portfolio, ranked #128.

HighVista Strategies first reported a position in ZYME in Q2 2020 and has held it in 8 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • HighVista Strategies held 34,013 shares of Zymeworks worth $889K as of Q2 2026.
  • HighVista Strategies sold 72 Zymeworks shares in Q2 2026, an estimated $1.83K.
  • Zymeworks made up 0.2% of HighVista Strategies's portfolio in Q2 2026, its #128 holding.
  • HighVista Strategies first reported a position in Zymeworks in Q2 2020 and has held it in 8 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.